Intravitreal LFG316 in Patients With Age-related Macular Degeneration (AMD)
Clinical trial NCT01527500 · COMPLETED
Trial details
- NCT number
- NCT01527500
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-25
- Primary completion
- 2015-06-24
- Enrollment
- 158
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.